Novel NTRK1 mutations associated with congenital insensitivity to pain with anhidrosis verified by functional studies.
Tai-Seung NamWenting LiSomy YoonGwang Hyeon EomMyeong-Kyu KimSung Taek JungSeok-Yong ChoiPublished in: Journal of the peripheral nervous system : JPNS (2018)
Congenital insensitivity to pain with anhidrosis (CIPA), also known as hereditary sensory and autonomic neuropathy type IV, features loss of pain sensation, decreased or absent sweating (anhidrosis), recurrent episodes of unexplained fever, self-mutilating behavior, and variable mental retardation. Mutations in neurotrophic receptor tyrosine kinase 1 (NTRK1) have been reported to be associated with CIPA. We identified four novel NTRK1 mutations in six Korean patients from four unrelated families. Of the four mutations, we demonstrated using a splicing assay that IVS14+3A>T causes aberrant splicing of NTRK1 mRNA, leading to introduction of a premature termination codon. An NTRK1 autophosphorylation assay showed that c.1786G>A (p.Asp596Asn) abolished autophosphorylation of NTRK1. In addition, Western blotting showed that c.704C>G (p.Ser235*) and c.2350_2363del (p.Leu784Serfs*79) blunted NTRK1 expression to undetectable levels. The four novel NTRK1 mutations we report here will expand the repertoire of NTRK1 mutations in CIPA patients, and further our understanding of CIPA pathogenesis.
Keyphrases
- end stage renal disease
- tyrosine kinase
- chronic pain
- ejection fraction
- chronic kidney disease
- neuropathic pain
- pain management
- peritoneal dialysis
- high throughput
- prognostic factors
- mental health
- epidermal growth factor receptor
- poor prognosis
- south africa
- patient reported
- heart rate variability
- blood pressure
- spinal cord injury
- long non coding rna